Copyright Reports & Markets. All rights reserved.

Global Nanotechnology Drug Delivery Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Nanotechnology Drug Delivery Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Nanocrystals
      • 1.4.3 Nanoparticles
      • 1.4.4 Liposomes
      • 1.4.5 Micelles
      • 1.4.6 Nanotubes
      • 1.4.7 Others
    • 1.5 Market by Application
      • 1.5.1 Global Nanotechnology Drug Delivery Market Share by Application (2014-2025)
      • 1.5.2 Neurology
      • 1.5.3 Oncology
      • 1.5.4 Cardiovascular/Physiology
      • 1.5.5 Anti-inflammatory/Immunology
      • 1.5.6 Anti-infective
      • 1.5.7 Other Applications
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Nanotechnology Drug Delivery Market Size
    • 2.2 Nanotechnology Drug Delivery Growth Trends by Regions
      • 2.2.1 Nanotechnology Drug Delivery Market Size by Regions (2014-2025)
      • 2.2.2 Nanotechnology Drug Delivery Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Nanotechnology Drug Delivery Market Size by Manufacturers
      • 3.1.1 Global Nanotechnology Drug Delivery Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Nanotechnology Drug Delivery Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Nanotechnology Drug Delivery Market Concentration Ratio (CR5 and HHI)
    • 3.2 Nanotechnology Drug Delivery Key Players Head office and Area Served
    • 3.3 Key Players Nanotechnology Drug Delivery Product/Solution/Service
    • 3.4 Date of Enter into Nanotechnology Drug Delivery Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Nanotechnology Drug Delivery Market Size by Type (2014-2019)
    • 4.2 Global Nanotechnology Drug Delivery Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Nanotechnology Drug Delivery Market Size (2014-2019)
    • 5.2 Nanotechnology Drug Delivery Key Players in United States
    • 5.3 United States Nanotechnology Drug Delivery Market Size by Type
    • 5.4 United States Nanotechnology Drug Delivery Market Size by Application

    6 Europe

    • 6.1 Europe Nanotechnology Drug Delivery Market Size (2014-2019)
    • 6.2 Nanotechnology Drug Delivery Key Players in Europe
    • 6.3 Europe Nanotechnology Drug Delivery Market Size by Type
    • 6.4 Europe Nanotechnology Drug Delivery Market Size by Application

    7 China

    • 7.1 China Nanotechnology Drug Delivery Market Size (2014-2019)
    • 7.2 Nanotechnology Drug Delivery Key Players in China
    • 7.3 China Nanotechnology Drug Delivery Market Size by Type
    • 7.4 China Nanotechnology Drug Delivery Market Size by Application

    8 Japan

    • 8.1 Japan Nanotechnology Drug Delivery Market Size (2014-2019)
    • 8.2 Nanotechnology Drug Delivery Key Players in Japan
    • 8.3 Japan Nanotechnology Drug Delivery Market Size by Type
    • 8.4 Japan Nanotechnology Drug Delivery Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Nanotechnology Drug Delivery Market Size (2014-2019)
    • 9.2 Nanotechnology Drug Delivery Key Players in Southeast Asia
    • 9.3 Southeast Asia Nanotechnology Drug Delivery Market Size by Type
    • 9.4 Southeast Asia Nanotechnology Drug Delivery Market Size by Application

    10 India

    • 10.1 India Nanotechnology Drug Delivery Market Size (2014-2019)
    • 10.2 Nanotechnology Drug Delivery Key Players in India
    • 10.3 India Nanotechnology Drug Delivery Market Size by Type
    • 10.4 India Nanotechnology Drug Delivery Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Nanotechnology Drug Delivery Market Size (2014-2019)
    • 11.2 Nanotechnology Drug Delivery Key Players in Central & South America
    • 11.3 Central & South America Nanotechnology Drug Delivery Market Size by Type
    • 11.4 Central & South America Nanotechnology Drug Delivery Market Size by Application

    12 International Players Profiles

    • 12.1 AbbVie, Inc.
      • 12.1.1 AbbVie, Inc. Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Nanotechnology Drug Delivery Introduction
      • 12.1.4 AbbVie, Inc. Revenue in Nanotechnology Drug Delivery Business (2014-2019)
      • 12.1.5 AbbVie, Inc. Recent Development
    • 12.2 Amgen Inc.
      • 12.2.1 Amgen Inc. Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Nanotechnology Drug Delivery Introduction
      • 12.2.4 Amgen Inc. Revenue in Nanotechnology Drug Delivery Business (2014-2019)
      • 12.2.5 Amgen Inc. Recent Development
    • 12.3 Celgene Corporation
      • 12.3.1 Celgene Corporation Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Nanotechnology Drug Delivery Introduction
      • 12.3.4 Celgene Corporation Revenue in Nanotechnology Drug Delivery Business (2014-2019)
      • 12.3.5 Celgene Corporation Recent Development
    • 12.4 Johnson & Johnson
      • 12.4.1 Johnson & Johnson Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Nanotechnology Drug Delivery Introduction
      • 12.4.4 Johnson & Johnson Revenue in Nanotechnology Drug Delivery Business (2014-2019)
      • 12.4.5 Johnson & Johnson Recent Development
    • 12.5 Merck & Co., Inc.
      • 12.5.1 Merck & Co., Inc. Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Nanotechnology Drug Delivery Introduction
      • 12.5.4 Merck & Co., Inc. Revenue in Nanotechnology Drug Delivery Business (2014-2019)
      • 12.5.5 Merck & Co., Inc. Recent Development
    • 12.6 Novartis International AG
      • 12.6.1 Novartis International AG Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Nanotechnology Drug Delivery Introduction
      • 12.6.4 Novartis International AG Revenue in Nanotechnology Drug Delivery Business (2014-2019)
      • 12.6.5 Novartis International AG Recent Development
    • 12.7 Perrigo Company plc
      • 12.7.1 Perrigo Company plc Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Nanotechnology Drug Delivery Introduction
      • 12.7.4 Perrigo Company plc Revenue in Nanotechnology Drug Delivery Business (2014-2019)
      • 12.7.5 Perrigo Company plc Recent Development
    • 12.8 Pfizer, Inc.
      • 12.8.1 Pfizer, Inc. Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Nanotechnology Drug Delivery Introduction
      • 12.8.4 Pfizer, Inc. Revenue in Nanotechnology Drug Delivery Business (2014-2019)
      • 12.8.5 Pfizer, Inc. Recent Development
    • 12.9 Teva Pharmaceutical Industries Ltd.
      • 12.9.1 Teva Pharmaceutical Industries Ltd. Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Nanotechnology Drug Delivery Introduction
      • 12.9.4 Teva Pharmaceutical Industries Ltd. Revenue in Nanotechnology Drug Delivery Business (2014-2019)
      • 12.9.5 Teva Pharmaceutical Industries Ltd. Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Nano-technology field has a potential to make significant impact on healthcare by delivering disease diagnosis, monitoring, implants, regenerative medicines and drug delivery, drug discovery for biomedicine. Since last few years, significant progress has been made in the field of nano-medicine (i.e. nano-technology), resulting in a number of products, including therapeutics and imaging agents, enabling more effective and less toxic therapeutic and diagnostic interventions.
      Nanotechnology drug delivery is a growing field and is witnessing increasing acceptance in health care applications. Nanotechnology drug delivery is widely used in the health care industry in applications such as neurology, anti-infective, cardiovascular disorders, and others. One important and active application area of nanotechnology drug delivery systems is to transport drugs to the final location of therapeutic intervention within the body.
      In 2018, the global Nanotechnology Drug Delivery market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Nanotechnology Drug Delivery status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Nanotechnology Drug Delivery development in United States, Europe and China.

      The key players covered in this study
      AbbVie, Inc.
      Amgen Inc.
      Celgene Corporation
      Johnson & Johnson
      Merck & Co., Inc.
      Novartis International AG
      Perrigo Company plc
      Pfizer, Inc.
      Teva Pharmaceutical Industries Ltd.

      Market segment by Type, the product can be split into
      Nanocrystals
      Nanoparticles
      Liposomes
      Micelles
      Nanotubes
      Others

      Market segment by Application, split into
      Neurology
      Oncology
      Cardiovascular/Physiology
      Anti-inflammatory/Immunology
      Anti-infective
      Other Applications

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Nanotechnology Drug Delivery status, future forecast, growth opportunity, key market and key players.
      To present the Nanotechnology Drug Delivery development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Nanotechnology Drug Delivery are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now